Literature DB >> 35256961

Peritoneal dialysis-associated peritonitis caused by Exophiala spinifera: A case report and review of literature.

Pongsagorn Jabgratog1, Tamonwan Chamroensakchai2, Talerngsak Kanjanabuch2,3,4, Jureeporn Ampaipun1, Nisa Thongbor5, Vedprakash G Hurdeal6,7, Kevin D Hyde6.   

Abstract

Exophiala spinifera is a black ascomycetous yeast and is responsible for phaeohyphomycosis. We provide the first case report of peritoneal dialysis (PD)-associated peritonitis in a female patient with progressive impairment of visual capacity. The infection was caused by a cutaneous infection of her hands. The patient responded well with PD catheter removal and 2-week antifungal medication. This case emphasizes the importance of hand hygiene and regular eye evaluation in preventing environment-bound infection in patients on PD. 2012 Elsevier Ltd. All rights reserved.
© 2022 The Authors.

Entities:  

Keywords:  Cutaneous infection; DR, Diabetic retinopathy; EUCAST, The European Committee on Antimicrobial Susceptibility Testing; Exophiala spinifera; FP, Fungal peritonitis; HD, Hemodialysis; ISPD, International Society for Peritoneal Dialysis; KOH, Potassium hydroxide; MIC, Minimal inhibitory concentration; PD, Peritoneal dialysis; Peritoneal dialysis; Peritonitis; Phaeohyphomycosis; SDA, Sabouraud dextrose agar

Year:  2022        PMID: 35256961      PMCID: PMC8897172          DOI: 10.1016/j.mmcr.2021.12.006

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN: 2211-7539


Introduction

Fungal peritonitis (FP) is rare but is associated with high morbidity and mortality rates [1]. Exophiala species are black yeast-like fungi found worldwide, inhabiting soil, wood, and dead plant matters. These fungi can cause chronic, localized infections of the cutaneous and subcutaneous tissues and cornea, known as phaeohyphomycosis [2]. In addition, the infection sometimes invades bone tissue causing bone necrosis [[3], [4], [5]]. Phaeohyphomycosis is not specific to Exophiala but refers to infections from dematiaceous or pigmented filamentous fungi which contain melanin in their cell walls, such as Bipolaris, Cladophialophora, Cladosporium, Fonsecaea, Phialophora, Ochronosis, Rhinocladiella, and Wangiella [6]. Systemic fungal infections are rare in people with normal host immunity but can be observed in the lungs, lymph nodes, and central nervous system in immunocompromised hosts [4,7]. There are eight case reports of Exophiala peritonitis in the literature caused by E. dermatitidis, E. jeanselmei, or E. xenobiotica [[8], [9], [10], [11], [12], [13], [14], [15]]. Here we provide the first report of peritoneal dialysis (PD)-associated peritonitis caused by E. spinifera, and review of the literature on Exophiala peritonitis in PD patients.

Case

A 52-year-old Thai female farmer with diabetic kidney failure and long-standing hypertension had been on PD (1.5% dextrose concentration x 4 exchanges/day) for over a year without infectious complications, at Trakan Phuet Phon Hospital, a community hospital in the northeastern part of Thailand. She was presented with cloudy effluent and dark granules inside her PD catheter without systemic signs of infection on day 0 (Fig. 1A). The patient was referred to Sunpasitthiprasong Hospital, a tertiary hospital, on the same day. The dialysate cell counts on day 0 showed numerous erythrocytes and leukocytes 26,000 cells/mm3 with 78% lymphocytes and 22% neutrophils. Her initial diagnosis was fungal peritonitis with intraluminal PD catheter colonization. A 2-week course of intravenous amphotericin B was immediately prescribed at 1 mg/kg/day, the PD catheter was removed, and hemodialysis (HD) was commenced on day +1.
Fig. 1

Numerous black granules distributed inside the peritoneal catheter (A) with dark brown septate hyphae with branches in 45° in the microscopic exam (KOH; 100x) (B). The dark colony on Sabouraud-Dextrose agar was demonstrated after ten days of incubation at 25 °C (C). In addition, many black specks and dirt were observed on her desquamated skin of both hands (D). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Numerous black granules distributed inside the peritoneal catheter (A) with dark brown septate hyphae with branches in 45° in the microscopic exam (KOH; 100x) (B). The dark colony on Sabouraud-Dextrose agar was demonstrated after ten days of incubation at 25 °C (C). In addition, many black specks and dirt were observed on her desquamated skin of both hands (D). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) The removed PD catheter and used PD bag were submitted to a central laboratory for microorganism identification. Direct microscopic examination with 20% potassium hydroxide (KOH) mount from the catheter revealed dark brown branching septate hyphae (Fig. 1B). Black colonies grew on Sabouraud dextrose agar (SDA) after seven days of incubation of both specimens. As the colony matured, the surface of colonies was gradually covered with a gray velvety mycelium (Fig. 1C). The taxon was identified as Exophiala spp. using API20c AUX kit (bioM'erieux, Marcy l’Etoile, France) based on biochemical reactions. Later on, the species was confirmed to be E. spinifera using the universal fungal primers ITS1/ITS4 to amplify the ITS gene region. Blast search against the nucleotide database in GenBank showed a 100% (1031/1031) identity to E. spinifera (accession number MN410626.1) (First BASE Laboratories, Singapore Science Park II, Singapore). The phylogenetic tree is shown in Fig. 2. Using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) Antifungal Clinical Breakpoint referenced to a microbroth dilution value of Aspergillus spp. [16], the pathogen was resistant to itraconazole (4μg/mL), fluconazole (>64μg/mL), and caspofungin (>64μg/mL) and susceptible to amphotericin B and voriconazole with minimal inhibitory concentrations (MICs) of 0.25 and 1.0 μg/mL, respectively. The patient responded well to the antifungal medication, as shown by the modified Edmonton Symptom Assessment System score decreasing from 19 at the onset of infection to zero. However, the patient had a decreased visual acuity due to proliferative diabetic retinopathy (DR), and the caregiver was unavailable. Therefore, the physician permanently transferred the patient to HD.
Fig. 2

The phylogenetic tree of the identified organism is consistent with E. spinifera.

The phylogenetic tree of the identified organism is consistent with E. spinifera. To define the etiology of the infection, the physician performed a root-cause analysis. The patient had DR in both eyes, which significantly affected her visual acuity at the initiation of PD. However, the patient could perform PD bag exchange by herself without a caregiver. The level of visual impairment became worse prior to the episode of infection; however, the patient did not report this information to her PD care team and continued to perform the exchange by herself. PD bag exchange and aseptic techniques were properly conducted, but reluctance was detected during the bag exchange steps. However, many black specks and dirt were observed in desquamated skin on her palms (Fig. 1D). Therefore, fungal colonization on the peel-off skin was suspected. Skin flakes were cultured, and the fungus recovered was the same species as the pathogen causing the peritonitis. Therefore, it is concluded that palm colonization by E. spinifera might be the most likely source of the infections. The skin infection was eradicated with a month course of topical ketoconazole and meticulous hand hygiene practice.

Discussion

Exophiala species are dematiaceous fungi classified within Herpotrichiellaceae (Eurotiomycetes/Chaetothyriales) which have a well-established etiology of phaeohyphomycosis [17]. Exophiala dermatitidis and E. jeanselmei are relatively common pathogens. This case represents the first case of PD-associated peritonitis caused by E. spinifera. Eight cases of Exophiala peritonitis have been reported in PD patients since 1983 (Table 1). There are three males (38%) with an average age of 43 (2–66) years, and two cases presenting with concomitant intraluminal colonization of Exophiala.
Table 1

Demographic and treatment outcome of Exophiala peritonitis.

NoGenderAges (years)Identified organismDiagnostic methodUnderlying conditionAssociated findingAntifungal therapyCatheter removalOutcomeReference
1M42E. jeanselmeiCultureNANoFC and AMBNoDiedKerr 1983 [8]
2M39E. dermatitidisCultureGNNoFCZYesSurvivedLye 1993 [9]
3F19E. jeanselmeiCultureCongenitalCath.AMBYesSurvivedAgarwal 1993 [10]
4F57E. jeanselmeiCultureAINCath.FC and FCZYesSurvivedRemon 1996 [11]
5F53E. dermatitidisCultureNANoFCZYesSurvivedVlassopoulos 2001 [12]
6F55E. dermatitidisCulturePKDNoAMBYesSurvivedGreig 2003 [13]
7M66E. xenobioticaSeq.DM, HT, CADESIAMBYesSurvivedLau 2003 [14]
8F2E. dermatitidisCulture, Seg.NoneNoVRCYesSurvivedPinheiro 2019 [15]
9F52E. spiniferaSeq.DM, HTCath.AMBYesSurvivedThe present case

Abbreviations: AIN, acute interstitial nephritis; AMB, amphotericin B; cath, catheter colonization; CAD, coronary artery disease; DM, diabetes mellitus; FCZ; fluconazole; FC, flucytosine; GN, glomerulonephritis; HT, hypertension; HIV, human immunodeficiency viruses; NA, not available; PKD, polycystic kidney disease; Seq, gene sequencing; UK, United Kingdom; USA, United States of America; VRC, voriconazole.

Demographic and treatment outcome of Exophiala peritonitis. Abbreviations: AIN, acute interstitial nephritis; AMB, amphotericin B; cath, catheter colonization; CAD, coronary artery disease; DM, diabetes mellitus; FCZ; fluconazole; FC, flucytosine; GN, glomerulonephritis; HT, hypertension; HIV, human immunodeficiency viruses; NA, not available; PKD, polycystic kidney disease; Seq, gene sequencing; UK, United Kingdom; USA, United States of America; VRC, voriconazole. Since no specific recommendations are made over this type of fungal pathogen [18], the 2016 International Society for Peritoneal Dialysis (ISPD) Peritonitis Guidelines [19] only recommend that “treatment with an appropriate antifungal agent be continued for at least 2 weeks after catheter removal.” In all cases of Exophiala peritonitis with PD catheter removal, favorable outcomes with complete/partial resolution were described after complete treatment (7/7, 100%), while only one case with catheter retained in-situ was resilient [8]. Table 1 indicated that amphotericin B is the most common antifungal agent used to treat Exophiala peritonitis, resulting in complete remission in 4 out of 5 cases [10,13,14]. The second typical therapy is fluconazole, with 100% effectiveness in eliminating the infection [9,11,12]. Despite lacking a standard treatment of E. spinifera peritonitis [18] and its rarity, amphotericin B administration for two weeks with early catheter removal provided an excellent clinical outcome in accordance with the in-vitro MIC results. Although the source of the infection is inconclusive in the presented case, superficial fungal infection of the patient's desquamated palm skin is the most probable explanation since the same pathogen was found on the patient's hands. Impeccable hand hygiene is crucial during PD bag exchange in preventing peritonitis. Any visibly dirty hands require washing with antiseptic soap. Patients, healthcare providers, and patient caregivers should be aware of the importance of proper hand hygiene protocols [20]. If the patient's hand is infected, treatment should be started. Self-performing bag exchanges should be withheld, or sterile gloves should be used. Blindness is relatively contraindicated to start PD; however, the cut-off level of visual impairment has not yet been discussed in the PD society. Notably, a decline in the patient's visual acuity over time should be considered, and periodic assessment should be incorporated as a part of routine PD care, particularly in patients with diabetic retinopathy and extreme age [21]. The skin infection should receive attention. In conclusion, we reported the first case of fungal peritonitis caused by E. spinifera associated with cutaneous infection of the patient's hands. Thus, this case raises awareness of the decline in patient visual acuity over time and reemphasizes the importance of hand hygiene in preventing peritonitis.

Competing interests

TK has received consultancy fees from VISTERRA as a country investigator and current recipient of the National Research Council of Thailand and received speaking honoraria from Astra Zeneca and Baxter Healthcare. All other authors have no financial conflicts of interest to declare.

Funding for your research

This study was supported by the Fund CU_FRB65_hea (19)_026_30_07, , Bangkok, Thailand and the (156/2560), Thailand.

Consent

The patient provided written informed consent to this case's publication. The consent form is available for review by the Editor of this journal.
  20 in total

1.  Wangiella dermatitidis peritonitis in a CAPD patient.

Authors:  D Vlassopoulos; G Kouppari; D Arvanitis; K Papaefstathiou; A Dounavis; A Velegraki; V Hadjiconstantinou
Journal:  Perit Dial Int       Date:  2001 Jan-Feb       Impact factor: 1.756

2.  Fatal Exophiala infections in China, with a report of seven cases.

Authors:  D-M Li; R-Y Li; G S de Hoog; M Sudhadham; D-L Wang
Journal:  Mycoses       Date:  2010-03-22       Impact factor: 4.377

3.  Exophiala jeanselmei peritonities in a patient on CAPD.

Authors:  C Remon; I J de la Calle; F Vallejo Carrion; S Perez-Ramos; E Fernández Ruiz
Journal:  Perit Dial Int       Date:  1996 Sep-Oct       Impact factor: 1.756

Review 4.  ISPD Catheter-Related Infection Recommendations: 2017 Update.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li; David W Johnson; Judith Bernardini; Jie Dong; Ana E Figueiredo; Yasuhiko Ito; Rumeyza Kazancioglu; Thyago Moraes; Sadie Van Esch; Edwina A Brown
Journal:  Perit Dial Int       Date:  2017 Mar-Apr       Impact factor: 1.756

Review 5.  Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM.

Authors:  Sharon C-A Chen; John Perfect; Arnaldo L Colombo; Oliver A Cornely; Andreas H Groll; Danila Seidel; Kerstin Albus; Joao N de Almedia; Guillermo Garcia-Effron; Nicole Gilroy; Cornelia Lass-Flörl; Luis Ostrosky-Zeichner; Livio Pagano; Tamas Papp; Riina Rautemaa-Richardson; Jon Salmanton-García; Andrej Spec; Joerg Steinmann; Sevtap Arikan-Akdagli; Dorothee E Arenz; Rosanne Sprute; Luisa Duran-Graeff; Tomas Freiberger; Corrado Girmenia; Michelle Harris; Souha S Kanj; Maryam Roudbary; Olivier Lortholary; Joseph Meletiadis; Esther Segal; Felipe Francisco Tuon; Nathan Wiederhold; Tihana Bicanic; Jagdish Chander; Yee-Chun Chen; Po-Ren Hsueh; Margaret Ip; Patricia Munoz; Isabel Spriet; Elvis Temfack; Luis Thompson; Anna Maria Tortorano; Aristea Velegraki; Nelesh P Govender
Journal:  Lancet Infect Dis       Date:  2021-08-19       Impact factor: 25.071

Review 6.  Phaeohyphomycosis.

Authors:  M G Rinaldi
Journal:  Dermatol Clin       Date:  1996-01       Impact factor: 3.478

7.  Early diagnosis of Exophiala CAPD peritonitis by 18S ribosomal RNA gene sequencing and its clinical significance.

Authors:  Susanna K P Lau; Patrick C Y Woo; Siu-kau Chiu; Kit-wah Leung; Raymond W H Yung; Kwok-yung Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2003-06       Impact factor: 2.803

Review 8.  Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.

Authors:  C M Kerr; J R Perfect; P C Craven; J H Jorgensen; D J Drutz; J D Shelburne; H A Gallis; R A Gutman
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

9.  Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  S Agarwal; N L Goodman; H H Malluche
Journal:  Am J Kidney Dis       Date:  1993-06       Impact factor: 8.860

Review 10.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.